Company Overview
- Headquarters
- 1150 Marina Village Pkwy, Alameda CA
- Website
- scribetx.com
- Employees
- 139
- Founded in
- 2018
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$50B
Who is Scribe Therapeutics
Scribe Therapeutics is a biotechnology company headquartered in Alameda, California. The company currently employs 108 individuals and has generated approximately $50 million in revenue. Scribe Therapeutics focuses on developing genetic medicines using its proprietary CRISPR by Design™ technology for genetic modification. This innovative approach aims to revolutionize the field of genetic medicine by providing a precise and efficient method for editing DNA. The company's CRISPR by Design™ platform offers a unique advantage in the development of genetic therapies. By employing a systematic and computational approach to CRISPR design, Scribe Therapeutics can engineer highly specific and effective gene editing solutions. This advanced technology enables the targeting of disease-causing genes with greater accuracy, potentially leading to more successful and safe treatments. For more information about Scribe Therapeutics and its groundbreaking work in genetic medicine, please visit their website at scribetx.com.
Company Leadership
Companies Similar to Scribe Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Scribe Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |